Page 194 - 89Zr-Immuno-PET:Towards a Clinical Tool to Guide Antibody-based Therapy in Cancer

Chapter 9
Supplemental Table 2 Relative difference between fitted and measured tissue activity concentrations
kidney liver lung spleen
89Zr- antiHER2 24 h p.i.
-1.1 (11.0) n=10
3.5 (5.6) n=10
-1.7 (6.1) n=10
1.4 (4.0) n=10
89Zr- antiHER2 48-96 h p.i.
3.3 (14.3) n=10
-3.3 (5.4) n=10
3.0 (10.9) n=10
-1.1 (4.9) n=10
%
89Zr- antiHER2 120-192 h p.i.
-1.1 (3.6) n=10
0.7 (2.1) n=10
-0.6 (3.0) n=10
0.2 (1.7) n=10
89Zr- antiPSMA 24 h p.i.
18 .2 (14.5) n=9
0.5 (11.2) n=8
1.1 (5.0) n=6
0.4 (8.2) n=8
89Zr- antiPSMA 48-120 h p.i.
-8.3 (6.6) n=9
0.6 (6.2) n=8
-1.0 (10.4) n=6
0.2 (6.6) n=8
89Zr- antiPSMA 144-168 h p.i.
2.0 (1.6) n=9
0.1 (1.5) n=8
0.0 (2.0) n=6
0.1 (1.4) n=8
Data presented as mean (SD) in
192